Showing results (191-200 of 364) with videos related to
Sort By:
Pageof 37
Journal of Drugs in Dermatology : JDD|October 7, 2020
Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric PatientsLawrence F Eichenfield, Boni Elewski, Jeffrey L Sugarman, et al.Dermatology and Therapy|October 23, 2018
Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their FamiliesEric L Simpson, Amy S Paller, Mark Boguniewicz, et al.Journal of Drugs in Dermatology : JDD|January 28, 2020
Topical Agents for the Treatment of Atopic DermatitisLawrence F. Eichenfield, Thomas Luger, Kim Papp, et al.International Journal of Dermatology|January 25, 2005
Use of pimecrolimus cream 1% (Elidel) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcomeLawrence F Eichenfield, Anne W Lucky, Richard G B Langley, et al.Journal of Drugs in Dermatology : JDD|February 2, 2024
Targeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic DermatitisLawrence F Eichenfield, Jonathan I Silverberg, Adelaide A Hebert, et al.Retinal Cases & Brief Reports|November 13, 2014
Characterization of kjellin syndrome using spectral-domain optical coherence tomography and fundus autofluorescenceRyan M Tarantola, Victoria Nguyen, Anita AgarwalJournal of Investigative Medicine High Impact Case Reports|January 20, 2022
Pre-excitation Due to Fascicular-Ventricular Pathway: An Electrocardiographic Diagnosis: A Case ReportRichard A Lange, Victoria Nguyen, Zainul AbedinPediatric Dermatology|January 10, 2018
Pediatric psoriasis: Evolving perspectivesLawrence F Eichenfield, Amy S Paller, Wynnis L Tom, et al.JAMA Dermatology|December 20, 2023
Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis: A Randomized Clinical TrialLawrence F Eichenfield, Sanela Tarabar, Seth Forman, et al.Dermatology and Therapy|May 17, 2026
Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 TrialMelinda Gooderham, Christopher G Bunick, JiaDe Yu, et al.Pageof 37